Brief: Inovio Pharmaceuticals' Phase 1/2 Study Results Published In Nature Communications
12/02/2025 13:18
Feb 12 (Reuters) - Inovio Pharmaceuticals INO.O :
* INOVIO PHARMACEUTICALS INC - PHASE 1/2 STUDY RESULTS OF
INO-3107
PUBLISHED IN NATURE COMMUNICATIONS
Source text: ID:nPn6FhLKra
Further company coverage: INO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inovio Pharmaceuticals
See all newsBrief: Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Inovio Q2 net loss narrows on warrant gain, lower costs
Brief: Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million